Abbott and WeightWatchers are working together to support people living with diabetes in achieving their health goals
- Two industry leaders join forces to empower people living with diabetes by providing information and knowledge to improve weight loss, glucose control and overall health
- The partnership will create a seamless, integrated experience between Abbott’s world-leading continuous glucose monitoring device1 and WeightWatchers’ number one doctor-recommended weight loss program2 to help people better understand and manage their diabetes and weight
ABBOTT PARKI will., August 4, 2022 /PRNewswire/ — Abbott (NYSE: ABT ) and WW International, Inc . (“WeightWatchers” or “WW”) today announced a strategic partnership to help people living with diabetes better understand and manage their diabetes and weight. Companies team up to integrate WeightWatchers’ diabetes-friendly weight management program with Abbott’s FreeStyle Libre portfolio® products to create a seamless mobile experience that will give people living with diabetes the information and knowledge they need to make healthy adjustments to their diet, improve their glucose levels and ultimately gain more control over their health their.
Maintaining a healthy weight and eating well is vital to living well with diabetes.3 However, for many people living with diabetes, deciding what to eat and sticking to a meal plan is the hardest part of managing diabetes.4 Through this partnership, participants can receive glucose information from Abbott’s FreeStyle Libre sensor-based technology that shows the impact of food choices, alongside empirically validated5 WeightWatchers dietary guidelines tailored for diabetes to help them achieve their healthiest living goals.
“We strive to put our customers at the heart of everything we do, and that includes forming strategic partnerships with key industry leaders like WeightWatchers to deliver new services and offerings that can significantly improve the quality of life of people living with diabetes”. he said Jared Watkin, senior vice president of Abbott’s diabetes care business. “Combining our world-leading1 FreeStyle Libre Glucose Monitoring Technology with WeightWatchers’ Number One Doctor Recommended Weight Loss Program,2 People with diabetes, especially those with type 2 diabetes who are treated less intensively by doctors, can have the knowledge they need to take control of their health.”
The two companies will work together to enable Abbott’s FreeStyle Libre continuous glucose monitoring systems and the WeightWatchers mobile app to share information so that people living with diabetes can view their glucose data alongside their diabetes-friendly plan by WeightWatchers.
“It is well established that lifestyle changes, including changes in eating patterns and activity routines, are a critical component of diabetes management and can help improve glycemic control.6” he said Sima Sistani, CEO of WeightWatchers. “We’ve partnered with Abbott, a leader in diabetes care, to empower people with diabetes to achieve their weight and healthy living goals while enjoying the foods they love and better managing their glucose levels.”
The partnership will initially focus on solutions for people living with diabetes indoors the United States in 2023.
Abbott is a global leader in healthcare that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the healthcare spectrum, with leading businesses and products in diagnostics, medical devices, nutritional products and branded generics. Our 113,000 colleagues serve people in more than 160 countries.
Connect with Abbott at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.
About WW International, Inc.
WeightWatchers is a people-centric technology company powered by the world’s leading commercial weight management program. For nearly six decades, we’ve inspired millions of people to adopt healthy habits in real life. Through our comprehensive tools, expert coaches and community, members follow our proven, sustainable, science-based program focused on weight loss. To learn more about the WeightWatchers approach to healthy living, visit www.com. For more information about our global operations, please visit our corporate website at corporate.ww.com.
Indications and Important Safety Information
FreeStyle Libre 14 Day System: Failure to use the FreeStyle Libre 14 Day System as directed on the labeling may result in missing a serious low or high glucose event and/or treatment decision, resulting in injury. If readings don’t match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when needed or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety information.
FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use the FreeStyle Libre 2 or FreeStyle Libre 3 systems as directed in the labeling may result in missing a serious low or high glucose event and/or treatment decision, resulting in injury. If your glucose alarms and readings don’t match your symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when needed or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety information.
1Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre portfolio compared to the number of users for other leading personal use, sensor-based glucose monitoring systems.
2 Based on a 2020 IQVIA survey of 14,000 physicians who recommend weight loss programs to patients.
3 Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, Mitri J, Pereira RF, Rawlings K, Robinson S, Saslow L, Uelmen S, Urbanski PB, Yancy WS Jr. Nutritional Therapy for Adults with Diabetes or Prediabetes: A Consensus Report. Diabetes Care. May 2019; 42(5):731-754. doi: 10.2337/dci19-0014. Epub 2019 Apr 18. PMID: 31000505; PMCID: PMC7011201.
4 American Diabetes Association. “5. Facilitating behavior change and well-being to improve health outcomes: standards of medical care in diabetes-2021.” Diabetes Care 44, no. Supplement 1 (2021): S53-S72.
5 Apolzan JW, LaRose JG, Anton SD, et al. A weight management program tailored for adults with type 2 diabetes: Effects on glycemic control. Poster presented at: American Diabetes Association 82nd Scientific Sessions; June 5-6, 2022; New Orleans, Los Angeles.
6 American Diabetes Association. Lifestyle Management: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(1):S46–S60. https://doi.org/10.2337/dc19-S005
For more information: Abbott Media: Samantha Thai, [email protected], (510) 708-9451; WW Media: Nicole Penn, [email protected], (917) 734-0802; Abbott Financial: Mike Comilla, [email protected], (224) 668-1872